Picture of RLS Global AB logo

RLS RLS Global AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: RLS: First Results From Database For ChloraSolv01

July 9 (Reuters) - RLS Global AB  RLSC.ST :
    * RLS CLINICAL TRIAL - CHLORASOLV01 - IS COMPLETED AND THE
RESULT
IS TO BE ANALYZED
    * DATABASE FOR CHLORASOLV01 IS CLOSED AND RLS HAS RECEIVED
FIRST
STATISTICAL REPORT AND RESULTS
    * CHLORASOLV01 IS A PILOT STUDY IN WHICH PATIENT WITH
CHRONIC
ULCERS ON LOWER LEG OR FOOT IS TREATED WITH CHLORASOLV FOR FIVE
WEEKS
    * STUDY ENDPOINTS INCLUDE FOR EXAMPLE REDUCTION OF
DEVITALIZED
TISSUE (NECROTIC TISSUE) AND REDUCTION OF WOUND SIZE.

Source text for Eikon:  ID:nWkrc3lKNh 
Further company coverage:  RLSC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on RLS Global AB

See all news